NCT03750513View on ClinicalTrials.gov

LET Optimized IMPT in Treating Pediatric Patients With Ependymoma

PHASE1RecruitingINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

April 1, 2019

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Anaplastic EpendymomaEpendymoma
Interventions
RADIATION

Linear Energy Transfer-Optimized Intensity Modulated Proton Therapy

Given LET optimized IMPT

OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Questionnaire Administration

Ancillary studies

Trial Locations (2)

77030

RECRUITING

M D Anderson Cancer Center, Houston

02114

NOT_YET_RECRUITING

Massachusetts General Hospital Cancer Center, Boston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER